Royal London Asset Management
TDOC icon

Royal London Asset Management’s Teladoc Health TDOC Stock Holding History

Royal London Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-53,551
Closed -$1.78M – 673
2022
Q2 		$1.78M Buy
53,551
+1,502
+3% +$63.8K 0.01% 609
2022
Q1 		$3.75M Buy
52,049
+1,651
+3% +$119K 0.01% 555
2021
Q4 		$4.63M Sell
50,398
-2,345
-4% -$280K 0.02% 513
2021
Q3 		$6.68M Sell
52,743
-2,289
-4% -$333K 0.03% 422
2021
Q2 		$9.15M Buy
55,032
+15,783
+40% +$2.56M 0.04% 351
2021
Q1 		$7.13M Buy
39,249
+2,028
+5% +$470K 0.03% 380
2020
Q4 		$7.44M Buy
37,221
+10,762
+41% +$2.19M 0.04% 339
2020
Q3 		$5.75M Buy
+26,459
New +$5.6M 0.03% 362

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal London Asset Management's TDOC Position: Q3 2022 in Review

Royal London Asset Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 53,551 shares — an estimated $1.78M sold.

Royal London Asset Management first reported a position in TDOC in Q3 2020 and held it in 8 quarters. The position peaked at $9.15M in Q2 2021. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Royal London Asset Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Royal London Asset Management sold 53,551 Teladoc Health shares in Q3 2022, an estimated $1.78M.
  • Royal London Asset Management first reported a position in Teladoc Health in Q3 2020 and held it in 8 quarters.
  • Royal London Asset Management's Teladoc Health position peaked at $9.15M in Q2 2021.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Royal London Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.